$UROV Urovant Sciences Ltd. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Urovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Urovant Sciences Ltd.. Insider overview, share value development, latest insider transactions and email notifications about new events in Urovant Sciences Ltd. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: UROV
Company Address: 5281 CALIFORNIA AVENUE SUITE 100 IRVINE 92617
Urovant Sciences Ltd. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | PEO; CEO/Urovant Sc ... | Payment of Exercise | F | 16.11 | 4,095 | 65,970 | 8,385 | 12.5 K to 8.4 K (-32.81 %) |
| Jan 08 2021 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO/Urovant Science ... | Payment of Exercise | F | 16.09 | 5,810 | 93,483 | 141,348 | 147.2 K to 141.3 K (-3.95 %) |
| Jan 08 2021 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Payment of Exercise | F | 16.09 | 4,761 | 76,604 | 124,447 | 129.2 K to 124.4 K (-3.68 %) |
| Jul 23 2020 | UROV | Urovant Sciences L ... | Hindman James M. | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jul 23 2020 | UROV | Urovant Sciences L ... | Hindman James M. | Director | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Jul 23 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jul 23 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
| Jul 23 2020 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jul 23 2020 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
| Jul 23 2020 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jul 23 2020 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
| Jun 03 2020 | UROV | Urovant Sciences L ... | Johnston Walt | SVP, Commercial, US ... | Option Exercise | A | 10.64 | 69,197 | 736,256 | 69,197 | |
| Jun 03 2020 | UROV | Urovant Sciences L ... | Johnston Walt | SVP, Commercial, US ... | Grant | A | 0.00 | 108,647 | 0 | 108,647 | 0 to 108.6 K |
| Jun 01 2020 | UROV | Urovant Sciences L ... | Hindman James M. | Director | Option Exercise | A | 10.53 | 61,000 | 642,330 | 61,000 | |
| May 04 2020 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO/Urovant Science ... | Grant | A | 0.00 | 83,149 | 0 | 145,277 | 62.1 K to 145.3 K (+133.83 %) |